ECAT ECAT
Company Profile ↓Company Overview
ECAT (ECAT) is a publicly traded company listed on with a market capitalization of $1.30B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 6.1.
Maintains a net profit margin of 98.7%.
Carries low leverage with a debt-to-equity ratio of 0.02.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $216.21M (-11.6% YoY); net profit $213.37M.
- Trailing 12 Months Year-on-year growth — revenue -11.6%, earnings -11.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -11.61% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -11.32% |
Stock Price Performance
| 1 Year: | -0.71% |
| 6 Months: | -0.40% |
| 3 Months: | -8.49% |
| 1 Month: | -5.07% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)34.41 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 98.7%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | -311.17M | 297.44M | 244.60M | 216.21M |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 1.73M | 2.52M | 4.01M | 1.16M |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | 0 | - | 868 | 1.33K | 12.77K |
| Pretax Income | - | -312.90M | 294.92M | 240.60M | 213.37M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -312.90M | 294.92M | 240.60M | 213.37M |
| Diluted EPS | - | -2.87 | 2.91 | 2.37 | 2.15 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 2.03B | 1.98B | 1.90B | 1.79B |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | - | 2.77M | 3.69M | 4.27M | 3.34M |
| Inventory | - | - | - | - | - |
| Receivables | - | 125.31M | 19.32M | 7.53M | 33.91M |
| Total Liabilities | - | 324.22M | 139.15M | 151.60M | 182.33M |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - |
| Total Debt | 5.97K | - | - | - | 382.38K |
| Total Equity | - | 1.70B | 1.84B | 1.74B | 1.61B |
| Shares Outstanding | - | 102.38M | 101.89M | 99.35M | 99.47M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 185.87M | 165.61M | 338.43M | 344.62M |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | - | -171.36M | -160.78M | -334.39M | -347.23M |
| Capital Expenditure | - | - | - | - | - |
| Free Cash Flow | - | 185.87M | 165.61M | 338.43M | 344.62M |
| Net Change in Cash | - | 14.50M | 4.83M | 4.04M | -2.60M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 100.6% | 99.2% | 98.4% | 98.7% |
| ROE % | - | -18.4% | 16.0% | 13.8% | 13.3% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ECAT
Saba Capital Management sells $334k of BlackRock ECAT stock - Investing.com
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOSzM4T3JENmNZUHVERUxxRHJiRzNSZVp1UzFuSG1nQlBVbVcxN0JvcUNSSjZ6TWQteHlINU0waDNEUG1TSGdNOXVNRGd2SWJXZ1FrSG1DcEd1d0tRUkxGWUptZGQzWDlTOERxWUhCYkQxRk4zTEZyeXpvaTVVMWpSMWNadGlSLWFOd01wbE…
Saba Capital Management sells $334k of BlackRock ECAT stock By Investing.com - Investing.com South Africa
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNSzBVUlV6OWVQazNQZC1YbGNNY3hNZjljY1BCeHhQeDQ5b0M0X240N2syV2tIck8tRmZqRnp4R1RpVHQyMVdfQUhvY0s0WjE2aUtaZFBxT3FuUWJvaHRaRWlJM0VENFNzbXNlZkZnaDhUcUgxejM2MHVhblJIeThJNzFZTU12TWthWXJqRV…
Why (ECAT) Price Action Is Critical for Tactical Trading - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxOU0RWN3JRcVg3N1doNnJtRjQzSldZeENPT29Wc0l3MTJUbkhURDBpWDBGSVNiMEJEUzZZMmNXalV6enl1ZjlsQ1VzQ2ZSNnJ0Qmw1a1p1aVgtdGhGN1dHa0JTV1NUSTZJS3Z3WVkzc19jbGg4ZnRVaUNCSk9aTVhYNDJiUGZpU0pCdXQ0eG…
ECAT: Dividend May Be Reduced Following Saba Capital Drama - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxPSUpRX0ZCS2F5czk0eHY4RzhGbk9hTTZsengzUUFDSDdNaHVwWFpOMnJwazdXRTNXMno0dnBpdHpfSXhVd2JpTUlzcE1QWlg1czBqZC1IaUg3Y0ltaEZGYzNSZ3ZaZkM3NlQ5aEZTcU40VGlwMDRpNnZXRmxyQkp2THQ3LWpTNDBEcnM1cE…
Saba Capital sells $675,333 in BlackRock ECAT shares - Investing.com
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPUjNic0hVc1dfbzZ3MkN6VzhQODVYWmlBSm5RMzZyVzluYzVla0ZBbHQ3Vlp5SHZmRzN4SUt5S3FhRFNCVTNyYV9OZ2NtaUZMaEYxd2lsTGVxSFMtVE1PaXhGajRLNWs3T0lrZ0NzRzRzOEVUVnRreUhrdGtMajJjX0wyb1A3WWk2SEpteV…
Saba Capital sells $675,333 in BlackRock ECAT shares By Investing.com - Investing.com Nigeria
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxPZmk4MTJkUG03TjNCZDJKdE0zT0xIaXhFc0t5dEhtQWhYd2ZXVGVuUEJqdTBMT2dQVUtKMnQ4cENacVdTaGdmLUFHV1FsYzBqQTRBbzhBcGstTmtPeWp3czdhcnBrcXdBSGdUdHFneG95TUEtNmI3VzIzNHNEdkZ2LTd2WWZZNTdrTy0xUF…
ECAT — Frequently Asked Questions
What is the current share price of ECAT?
As of 2026-10-23 16:27 PDT, ECAT trades at $13.11 on NASDAQ/NYSE. Its 52-week range is $11.80 to $14.99.
What is the market capitalisation of ECAT?
ECAT has a market capitalisation of $1.30B on NASDAQ/NYSE.
What is the P/E ratio of ECAT?
ECAT trades at a trailing price-to-earnings (P/E) ratio of 6.10. Its price-to-book (P/B) ratio is 0.81.
What is the return on equity (ROE) of ECAT?
ECAT has a return on equity (ROE) of 13.26%.
Is ECAT a good stock to buy?
This page provides a data-driven analysis of ECAT, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.